Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation.

about

Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial.

P2860

Q38385536-478CCB1B-EF08-4C0A-A7E4-8A59575C9925

P2860

Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation.

Item

http://www.wikidata.org/entity/Q38617612

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Therapeutic strategies for cyt ...... opoietic cell transplantation.

@en

type

Item

label

Therapeutic strategies for cyt ...... opoietic cell transplantation.

@en

prefLabel

Therapeutic strategies for cyt ...... opoietic cell transplantation.

@en

P1476

Therapeutic strategies for cyt ...... opoietic cell transplantation.

@en

P2093

Jessica El-Asmar

http://www.w3.org/2001/XMLSchema#string

Mahmoud Aljurf

http://www.w3.org/2001/XMLSchema#string

Marwan Shaheen

http://www.w3.org/2001/XMLSchema#string

Mohamed A Kharfan-Dabaja

http://www.w3.org/2001/XMLSchema#string

Taiga Nishihori

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions of cytomegalovirus infection and disease in transplant recipients

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Fully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott RealTime CMV assay in the era of the CMV international standard

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.

Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation.

Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis.

Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy.

Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.

P304

1059-1071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.15.70

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26507225

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation.

about

P2860

P2860

Therapeutic strategies for cytomegalovirus in allogeneic hematopoietic cell transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921